BHV-1 glycoprotein 1 and recombinant interleukin 1 efficiently elicit mucosal IgA response

By Gao Y.   Daley M.J.   Splitter G.A.  

Vaccine, Vol. 13, Iss. 9, 1995-06 ,pp. : 871-877

Elsevier

Access to resources Recommend Favorite

Microparticles in MF59, a potent adjuvant combination for a recombinant protein vaccine against HIV-1

By O'Hagan D.T.   Ugozzoli M.   Barackman J.   Singh M.   Kazzaz J.   Higgins K.   Vancott T.C.   Ott G.  

Vaccine, Vol. 18, Iss. 17, 2000-03 ,pp. : 1793-1801

Elsevier

Access to resources Recommend Favorite

Immunization with E. coli produced recombinant T. bondii SAG1 with alum as adjuvant protect mice against lethal infection with Toxoplasma gondii

By Petersen E.   Nielsen H.V.   Christiansen L.   Spenter J.  

Vaccine, Vol. 16, Iss. 13, 1998-08 ,pp. : 1283-1289

Elsevier

Access to resources Recommend Favorite

The adjuvant combination monophosphoryl lipid A and QS21 switches T cell responses induced with a soluble recombinant HIV protein from Th2 to Th1

By Moore A.   McCarthy L.   Mills K.H.G.  

Vaccine, Vol. 17, Iss. 20, 1999-06 ,pp. : 2517-2527

Elsevier

Access to resources Recommend Favorite

IL-18 potentiates the adjuvant properties of IL-12 in the induction of a strong Th1 type immune response against a recombinant antigen

By Eberl M.   Beck E.   Coulson C.P.S.   Okamura H.   Wilson W.R.A.   Mountford M.A.P.  

Vaccine, Vol. 18, Iss. 19, 2000-04 ,pp. : 2002-2008

Elsevier

Access to resources Recommend Favorite